Pulmonology News

Metered-dose inhalers had higher estimated greenhouse gas emissions than dry-powder and soft-mist inhalers but cost less than these propellant-free inhalers, according to a research letter published in JAMA.

Odds for asthma symptoms, COPD and chronic bronchitis went up if individuals reported earlier “often/always” vs. “never” gum bleeding, according to a poster presented at the European Respiratory Society International Congress.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

The antiviral molnupiravir modestly reduces the risk for severe symptoms of COVID-19 and may also reduce the risk for long COVID, according to a randomized controlled trial.

Risks for respiratory viral infections increased among children with asthma who were exposed to high levels of floor cockroach and mouse airborne allergens, according to a study published in The Journal of Allergy and Clinical Immunology.

The next time you have patients who struggle with airway resistance, you may want to refer them to your local periodontist for a deep cleaning, according to a poster presented at the European Respiratory Society International Congress.

Dupilumab’s impact on exacerbation rate and lung function in adults with COPD and type 2 inflammation did not differ based on BODE index score, according to a poster presented at the European Respiratory Society International Congress.

In the first half of 2024, several U.S. health care professionals discussed the price of inhalers for patients with COPD on X, formerly Twitter, according to a tracker from Creation Healthcare.

Patritumab deruxtecan improved PFS compared with chemotherapy among certain patients with advanced non-small cell lung cancer, according to the agent’s manufacturer.